221 related articles for article (PubMed ID: 37173711)
1. Persistent and fatal severe acute respiratory syndrome coronavirus 2 infection in a patient with severe hypogammaglobulinemia: a case report.
Bedoya-Joaqui V; Gutiérrez-López MI; Caicedo PA; Villegas-Torres MF; Albornoz-Tovar LL; Vélez JD; Hidalgo-Cardona A; Tobón GJ; Cañas CA
J Med Case Rep; 2023 May; 17(1):194. PubMed ID: 37173711
[TBL] [Abstract][Full Text] [Related]
2. Severe acute respiratory syndrome coronavirus-2 Alpha variant (B.1.1.7), original wild-type severe acute respiratory syndrome coronavirus 2, and cytomegalovirus co-infection in a young adult with acute lymphoblastic leukemia, case report, and review of the possible cytomegalovirus reactivation mechanisms.
Amanati A; Shahriari M; Bordbar MR; Hedayati SB; Ziyaeyan M; Jamalidoust M; Kalani M; Heydari Marandi N
J Med Case Rep; 2023 Feb; 17(1):66. PubMed ID: 36765433
[TBL] [Abstract][Full Text] [Related]
3. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
4. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
5. Evolution of severe acute respiratory syndrome coronavirus 2 RNA test results in a patient with fatal coronavirus disease 2019: a case report.
Shao C; Liu H; Meng L; Sun L; Wang Y; Yue Z; Kong H; Li H; Weng H; Lv F; Jin R
Hum Pathol; 2020 Jul; 101():82-88. PubMed ID: 32437706
[TBL] [Abstract][Full Text] [Related]
6. Myoclonus status revealing COVID 19 infection.
Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
[TBL] [Abstract][Full Text] [Related]
7. Early use of airway pressure release ventilation in acute respiratory distress syndrome induced by coronavirus disease 2019: a case report.
Sinatra J; Salim RW; Tanoto EA; Hariyanto H
J Med Case Rep; 2022 Dec; 16(1):486. PubMed ID: 36575498
[TBL] [Abstract][Full Text] [Related]
8. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
9. Universal testing for severe acute respiratory syndrome coronavirus 2 in 2 Philadelphia hospitals: carrier prevalence and symptom development over 2 weeks.
Bender WR; Hirshberg A; Coutifaris P; Acker AL; Srinivas SK
Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100226. PubMed ID: 32954248
[TBL] [Abstract][Full Text] [Related]
10. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
[TBL] [Abstract][Full Text] [Related]
11. Persistent severe acute respiratory syndrome coronavirus 2 detection after resolution of coronavirus disease 2019-associated symptoms/signs.
Park SY; Yun SG; Shin JW; Lee BY; Son HJ; Lee S; Lee E; Kim TH
Korean J Intern Med; 2020 Jul; 35(4):793-796. PubMed ID: 32549526
[TBL] [Abstract][Full Text] [Related]
12. Severe acute respiratory syndrome coronavirus 2 reinfection in a coronavirus disease 2019 recovered young adult: a case report.
Awada H; Nassereldine H; Hajj Ali A
J Med Case Rep; 2021 Jul; 15(1):382. PubMed ID: 34271967
[TBL] [Abstract][Full Text] [Related]
13. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls.
DeBolt CA; Bianco A; Limaye MA; Silverstein J; Penfield CA; Roman AS; Rosenberg HM; Ferrara L; Lambert C; Khoury R; Bernstein PS; Burd J; Berghella V; Kaplowitz E; Overbey JR; Stone J
Am J Obstet Gynecol; 2021 May; 224(5):510.e1-510.e12. PubMed ID: 33221292
[TBL] [Abstract][Full Text] [Related]
14. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
15. Severe acute respiratory syndrome coronavirus 2-induced acute aortic occlusion: a case report.
Minalyan A; Thelmo FL; Chan V; Tzarnas S; Ahmed F
J Med Case Rep; 2021 Mar; 15(1):112. PubMed ID: 33653414
[TBL] [Abstract][Full Text] [Related]
16. Confirmed severe acute respiratory syndrome coronavirus 2 encephalitis in cerebrospinal fluid: a case report.
Ayuningtyas T; Natadidjaja RI; Octaviani C; Sahli F; Adlani H
J Med Case Rep; 2022 Apr; 16(1):154. PubMed ID: 35418102
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
18. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
19. Posterior reversible encephalopathy syndrome during convalescence from COVID-19.
Michel-Chávez A; García-Grimshaw M; Chávez-Martínez OA; Cantú-Brito C; Romero-Sánchez GT; Flores-Silva FD; Merayo-Chalico FJ; Martínez-Carrillo FM; Barrera-Vargas A; Valdés-Ferrer SI
Int J Neurosci; 2023 Jun; 133(6):672-675. PubMed ID: 34370958
[No Abstract] [Full Text] [Related]
20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
